Pipeline of Post Operative Pain H2 2017 report provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape. Post-Operative Pain Pipeline provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The Post-Operative Pain pipeline report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects.
Discount is available on Diarrhea report at http://www.reportsnreports.com/contacts/discount.aspx?name=1125812 .
Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Purchase This Single User License PDF Report of 191 pages at: http://www.reportsnreports.com/purchase.aspx?name=1125812 .
Key players are Abide Therapeutics Inc, AcelRx Pharmaceuticals Inc, Adynxx Inc, AngioChem Inc, Aoxing Pharmaceutical Company Inc, Camurus AB, Cara Therapeutics Inc, Center Laboratories Inc, Colby Pharmaceutical Company, Cytogel Pharma LLC, Dompe Farmaceutici SpA, DURECT Corp, Eupraxia Pharmaceuticals Inc, EyeGate Pharmaceuticals Inc, Fujimoto Pharmaceutical Corp, GW Pharmaceuticals Plc , Heron Therapeutics Inc more..
Post-Operative Pain – Drug Profiles : bupivacaine hydrochloride + meloxicam, buprenorphine hydrochloride + granisetron hydrochloride, A-100, ABD-1970, ARX-04, AYX-1, brimapitide, bupivacaine hydrochloride, CAM-2048, carbamazepine, CPC-111, CPC-123, CT-044, Cyt-1010, dexamethasone acetate, dexmedetomidine hydrochloride, DF-2755A, difelikefalin, ECP-1014, fadolmidine hydrochloride, fentanyl, gonyautoxin, HTX-009, HYLP-002, IPP-102199, ketorolac tromethamine, lacosamide, levorphanol tartrate ER, MDT-10013, meloxicam, meloxicam ER, MR-309, nabiximols, nalbuphine hydrochloride more..
List of Figures
Number of Products under Development for Post-Operative Pain, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Top 10 Routes of Administration, H2 2017
Number of Products by Stage and Top 10 Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
ReportsandReports.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441